JP2023521030A5 - - Google Patents
Info
- Publication number
- JP2023521030A5 JP2023521030A5 JP2022560218A JP2022560218A JP2023521030A5 JP 2023521030 A5 JP2023521030 A5 JP 2023521030A5 JP 2022560218 A JP2022560218 A JP 2022560218A JP 2022560218 A JP2022560218 A JP 2022560218A JP 2023521030 A5 JP2023521030 A5 JP 2023521030A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063005792P | 2020-04-06 | 2020-04-06 | |
| US63/005,792 | 2020-04-06 | ||
| PCT/US2021/025732 WO2021207054A1 (en) | 2020-04-06 | 2021-04-05 | Methods of reducing plasma level of macrophage migratory inhibitory factor in patients with ibudilast |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023521030A JP2023521030A (ja) | 2023-05-23 |
| JPWO2021207054A5 JPWO2021207054A5 (https=) | 2024-04-15 |
| JP2023521030A5 true JP2023521030A5 (https=) | 2024-04-15 |
Family
ID=75674991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560218A Pending JP2023521030A (ja) | 2020-04-06 | 2021-04-05 | イブジラストを用いる、患者におけるマクロファージ遊走性阻止因子の血漿レベルの減少方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12213966B2 (https=) |
| EP (1) | EP4132521A1 (https=) |
| JP (1) | JP2023521030A (https=) |
| CN (1) | CN115335049A (https=) |
| CA (1) | CA3174413A1 (https=) |
| WO (1) | WO2021207054A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2745814C1 (ru) * | 2020-06-05 | 2021-04-01 | Закрытое Акционерное Общество "Биокад" | Водная фармацевтическая композиция левилимаба и ее применение |
| CA3226898A1 (en) | 2021-07-26 | 2023-02-02 | Kazuko Matsuda | Ibudilast for preventing eye cancer metastasis |
| US12042485B2 (en) | 2021-10-07 | 2024-07-23 | Medicinova, Inc. | Methods of minimizing cancer metastasis |
| WO2023150093A1 (en) * | 2022-02-01 | 2023-08-10 | Medicinova, Inc. | Ibudilast for use in the treatment of post-covid conditions |
| JP2025523822A (ja) * | 2022-07-13 | 2025-07-25 | メディシノバ・インコーポレイテッド | イブジラストの注射用製剤 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1106178T3 (da) | 1998-08-10 | 2005-02-28 | Kyorin Seiyaku Kk | Anvendelse af ibudilast til fremstilling af et lægemiddel til behandling af dissemineret sklerose |
| SG148198A1 (en) | 2003-11-21 | 2008-12-31 | Combinatorx Inc | Methods and reagents for the treatment of inflammatory disorders |
| MX2007006777A (es) | 2004-12-06 | 2007-08-06 | Avigen Inc | Ibudilast para tratar dolor neuropatico y sindromes asociados. |
| CA2653345A1 (en) * | 2006-05-31 | 2007-12-13 | Avigen, Inc. | Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity |
| CA2970273C (en) | 2007-07-11 | 2020-04-14 | Medicinova, Inc. | Treatment of progressive neurodegenerative disease with ibudilast |
| US20110028510A1 (en) * | 2009-02-18 | 2011-02-03 | Combinatorx (Singapore) Pte. Ltd. | Compositions, Methods, and Kits for Treating Influenza Viral Infections |
| EP3558301A4 (en) * | 2016-12-22 | 2020-07-29 | MediciNova, Inc. | METHOD FOR TREATING GLIOBLASTOMA MULTIFORME WITH IBUDILAST |
| CA3023014C (en) * | 2017-11-06 | 2023-09-26 | Stalicla Sa | Pharmaceutical composition for treatment of autism |
| US20190247369A1 (en) * | 2018-02-12 | 2019-08-15 | Medicinova, Inc. | Methods of suppressing myeloid-derived suppressor cells in patients |
-
2021
- 2021-04-05 EP EP21721728.0A patent/EP4132521A1/en active Pending
- 2021-04-05 JP JP2022560218A patent/JP2023521030A/ja active Pending
- 2021-04-05 WO PCT/US2021/025732 patent/WO2021207054A1/en not_active Ceased
- 2021-04-05 US US17/222,673 patent/US12213966B2/en active Active
- 2021-04-05 CA CA3174413A patent/CA3174413A1/en active Pending
- 2021-04-05 CN CN202180024762.3A patent/CN115335049A/zh active Pending
-
2025
- 2025-01-10 US US19/016,999 patent/US20250221969A1/en active Pending